Nektar Therapeutics
NASDAQ:NKTR
Nektar Therapeutics
NASDAQ:NKTR
Price:
1.77 USD
1.14%
Market Closed
Updated:
May 15, 2024
Operating Margin
Nektar Therapeutics
Nektar Therapeutics
-145.7%
Current
-297%
Average
7.2%
Industry
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin
=-145.7%
Operating Profit
/
-131.3m
Revenue
90.1m
Operating Margin Across Competitors
| Country | US |
| Market Cap | 325m USD |
| Operating Margin |
-146%
|
| Country | JP |
| Market Cap | 776 550.9T JPY |
| Operating Margin |
-83%
|
| Country | US |
| Market Cap | 726.1B USD |
| Operating Margin |
32%
|
| Country | DK |
| Market Cap | 4.1T DKK |
| Operating Margin |
45%
|
| Country | UK |
| Market Cap | 440.4B GBP |
| Operating Margin |
3%
|
| Country | US |
| Market Cap | 364.3B USD |
| Operating Margin |
28%
|
| Country | US |
| Market Cap | 325.9B USD |
| Operating Margin |
10%
|
| Country | UK |
| Market Cap | 189.8B GBP |
| Operating Margin |
18%
|
| Country | CH |
| Market Cap | 182.9B CHF |
| Operating Margin |
28%
|
| Country | CH |
| Market Cap | 179.1B CHF |
| Operating Margin |
32%
|
| Country | US |
| Market Cap | 160.2B USD |
| Operating Margin |
19%
|
Profitability Report
View the profitability report to see the full profitability analysis for Nektar Therapeutics.
See Also
Discover More
What is Operating Margin?
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin
=-145.7%
Operating Profit
/
-131.3m
Revenue
90.1m
What is the Operating Margin of Nektar Therapeutics?
Based on Nektar Therapeutics's most recent financial statements, the company has Operating Margin of -145.7%.
You don't have any saved screeners yet
